About us
Biocartis is a privately owned biotech company that was founded in 2007 by Dr. Rudi Pauwels (Co-founder of Tibotec, Virco and Galapagos Genomics), Prof. Philippe Renaud (Prof. at EPFL), and Nader Donzel (Co-founder of Scitec laboratory Automation). Biocartis engages in the development of novel diagnostics technology platforms for low to highly multiplexed detection of molecular-based biomarkers. The Company is focused on the delivery of versatile and compact molecular diagnostic platforms whose ease of use and operational characteristics will lower the entry barrier to molecular diagnostic testing. Biocartis is based at the EPFL Science Park in Lausanne, Switzerland and at the High Tech Campus in Eindhoven, The Netherlands.
Biocartis is developing two innovative diagnostic platforms:
- A molecular diagnostics platform that fully integrates any sample preparation of nucleic acids, amplification, detection, and the generation of a result without user intervention.
- A multiplex detection platform that includes encoded microcarriers, a micofluidic cartridge, and an instrument for low- to high multiplexing detection of biomarkers.